Qishen Yiqi Dripping Pills improve cardiopulmonary function in post-percutaneous coronary intervention patients

Evaluation of the effect of Qishen Yiqi Dripping Pills on cardiopulmonary exercise tests in patients with coronary heart disease after percutaneous coronary intervention

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN83433606

Enrollment

100

Registered

2024-09-30

Start date

2024-01-01

Completion date

Unknown

Last updated

2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular protection observed in post-PCI patients with coronary heart disease (CHD) Circulatory System

Interventions

This is a randomized, double-blind, placebo-controlled study of the effects of Qishen Yiqi Dripping Pills on cardiopulmonary function, Chinese medicine symptom scale, and quality of life in patients w

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 25-80 years old 2. Patients with acute coronary syndrome after coronary interventional treatment 3. Traditional Chinese medicine Qi deficiency and blood stasis certificate (both certificates include: phlegm certificate, Yin deficiency, Yang deficiency certificate) 4. Co Cardiopulmonary exercise testing (CPET) contraindications

Exclusion criteria

Exclusion criteria: 1. Serious heart complications such as ventricular septal perforation 2. Cardiogenic shock and cardiac arrest 3. Vascular interventional treatment success but with vascular lesions with greater than 70% occlusion 4. Severe liver and kidney dysfunction, mental abnormalities, hematopoietic dysfunction, co-infection or severe immune system diseases 5. Pregnant or lactating women

Design outcomes

Primary

Measure	Time frame
Cardiopulmonary function is measured using Cardiopulmonary Exercise Testing at 3 months after PCI	—

Secondary

Measure	Time frame
1. Quality of life is measured using the 36-Item Short Form Survey Instrument (SF-36) at baseline, 1, 2 and 3 months after PCI 2. Cardiac function is measured using echocardiography at baseline and 3 months after PCI 3. Serum inflammatory markers (CRP, IL-6, TNFa, etc.) are measured using chemiluminescence at 3 months after PCI 4. Qi deficiency and blood stasis syndrome scores are measured by a Traditional Chinese medicine doctor using Traditional Chinese four ways of diagnosis including looking, listening, questioning and feeling the pulse 3 months after PCI.	—

Measure

Time frame

1. Quality of life is measured using the 36-Item Short Form Survey Instrument (SF-36) at baseline, 1, 2 and 3 months after PCI 2. Cardiac function is measured using echocardiography at baseline and 3 months after PCI 3. Serum inflammatory markers (CRP, IL-6, TNFa, etc.) are measured using chemiluminescence at 3 months after PCI 4. Qi deficiency and blood stasis syndrome scores are measured by a Traditional Chinese medicine doctor using Traditional Chinese four ways of diagnosis including looking, listening, questioning and feeling the pulse 3 months after PCI.

—

Countries

China

Contacts

Public ContactDeguo Wang

wangdeguo@wnmc.edu.cn+8618226726360

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026